More than ADLs: Assisted living now is about treatment, Silverado CEO says
By
Lois A. Bowers
Sep 30, 2024
Assisted living is a “whole different world” compared with 28 years ago, Silverado CEO Loren Shook told those attending a session at the National Investment Center for Seniors Housing & Care’s...
Falls requiring medical attention tied to later dementia diagnosis
By
HealthDay News
Oct 02, 2024
The authors say that the findings warrant cognitive screening after a fall resulting in an emergency department or inpatient encounter.
CMS officially removes one-time restriction for Alzheimer’s PET scan coverage
By
Aaron Dorman
Oct 17, 2023
Seniors covered by Medicare will now have expanded access to Alzheimer’s diagnostic PET scans after the CMS removed one-time restrictions.
Facility staff and families both struggle to figure out processes for dementia patients, report reveals
By
Kimberly Bonvissuto
Mar 20, 2024
It’s not just family caregivers who face challenges navigating dementia care — the nation’s healthcare workers also said they had difficulties providing care coordination through a complex healthcare...
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
The 5-Cog paradigm improves diagnosis, management of dementia
Jun 11, 2024
A threefold improvement was seen in dementia care actions with the 5-Cog paradigm, a culturally adept cognitive detection tool.
In-hospital delirium increases risk for functional disability, cognitive impairment
Jul 11, 2024
The findings were seen among older adults in the six months following a COVID-19 hospitalization.
More news for Friday, Nov. 3
By
Kimberly Bonvissuto
Nov 03, 2023
Neighoborhood environments can influence modifiable factors for Alzheimer’s, dementias … Former assisted living owner to undergo competency evaluation in exploitation case … Enhanced tai chi program...
Lifestyle intervention can improve cognition, function in early Alzheimer’s disease
Jun 13, 2024
A significant correlation was seen between lifestyle and both cognitive function and Aβ42/40 ratio.
Monoclonal antibodies provide small benefits in Alzheimer’s disease
Jan 26, 2024
Harms include increased risks for amyloid-related imaging abnormalities (ARIA)-edema, ARIA-hemorrhage and symptomatic ARIA-edema.